Diagnos Inc New (DGNOF) 0.0771 $DGNOF
DIAGNOS Announces Changes to its Board of Directors
Marketwire - Thu Jul 24, 3:01PM CDT
DIAGNOS Inc. ("DIAGNOS" or the "Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis and image processing, is pleased to announce the appointment of Mr. Lloyd M. Segal and Mr. Michael Singer as Directors of the Corporation following the resignations of Mr. Rich Baxter and Mr. Bruno Maruzzo.
DIAGNOS Announces Yet Another Expansion of Successful Program in the UAE
Marketwire - Tue Jul 22, 8:31AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today a further expansion of the agreement first announced on November 26th 2013, with the first expansion announced on March 11, 2014, to further increase screening capacity in the country.
DIAGNOS Announces Signing of Contract with Ministry of Health Owned Medical Center in the United Arab Emirates
Marketwire - Wed Jul 16, 8:30AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today the signing of a contract with Al Manama Medical Center for the deployment of a screening unit and usage of CARA in the Unite Arab Emirates, a project fully supported by the UAE Ministry of Health.
Persistence Capital Partners Files Early Warning Report
CNW Group - Thu Jul 10, 9:00PM CDT
Persistence Capital Partners LP ("PCP" , a leading Canadian private equity firm focused exclusively on investments in high growth opportunities in the healthcare field, is pleased to announce that, in connection with the completion of the three-cornered amalgamation (the "Amalgamation" among Warnex Inc. ("Warnex" and 8910979 Canada Inc., a wholly owned subsidiary of Diagnos Inc. ("Diagnos" which closed on July 8, 2014, PCP became a 13.76% shareholder of Diagnos.
DIAGNOS Completes Merger with Warnex Inc. and Announces the Issuance of Stock Warrants
Marketwire - Tue Jul 08, 2:35PM CDT
DIAGNOS Inc. ("DIAGNOS" (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce the closing of the merger (the "Merger" of Warnex Inc. ("WARNEX" with a wholly-owned subsidiary of DIAGNOS initially announced on May 5, 2014.
Shareholders of Warnex Approve the Amalgamation With Diagnos
Marketwire - Fri Jun 27, 10:42AM CDT
DIAGNOS Inc. ("DIAGNOS" (TSX VENTURE: ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis, and image processing, is pleased to announce that, at an annual and special meeting of the shareholders (the "Meeting" of Warnex Inc. ("Warnex" held yesterday, June 26, 2014, the shareholders of Warnex approved the terms of the amalgamation (the "Amalgamation" with a wholly-owned subsidiary of DIAGNOS initially announced on May 5, 2014. The Amalgamation was approved by 99.95% of Warnex shareholders voting in person or by proxy at the Meeting.
Warnex and Diagnos enter into a pre-amalgamation agreement
CNW Group - Mon Jun 02, 7:08AM CDT
Pursuant to a binding letter of agreement entered into with Diagnos on May 5, 2014, Warnex Inc. (TSXV: WNX.H) ("Warnex" is pleased to announce that it has entered into a pre-amalgamation agreement on May 30, 2014 (the "Pre-Amalgamation Agreement" with Diagnos Inc. ("Diagnos" , pursuant to which Warnex agreed to carry out an amalgamation (the "Amalgamation" under which Warnex will amalgamate with a wholly-owned subsidiary of Diagnos.
DIAGNOS Announces Closing of First Tranche of Private Placement
Marketwire - Tue Apr 01, 9:01AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces the closing of first tranche, consisting of 77 units (the "Unit" , for gross proceeds of $770,000, of a non-brokered private placement consisting of up to 125 units, for gross proceeds of up to $1,250,000 previously announced on February 25, 2014.
DIAGNOS Announces an Additional Expansion of Successful Program in the UAE
Marketwire - Tue Mar 11, 11:10AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis, and image processing, announced today a further expansion of the agreement announced on November 26th 2013 to further increase screening capacity in the country.
Understanding Credit and Banking Sector
by Sanderson Abel - All Africa Global Media - Wed Feb 26, 4:43AM CST
It is important to realise that efficient allocation of savings through the identification and funding of entrepreneurs with the best chances of successfully implementing innovative products and production processes are tools to achieve the growth objective as enunciated in the Zimbabwe Agenda for Sustainable Socio-Economic Transformation (Zim-Asset) programme.
DIAGNOS Announces Private Placement
Marketwire - Tue Feb 25, 8:58AM CST
DIAGNOS inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces the intention of undertaking a non-brokered private placement consisting of up to 125 units (the "Unit" , for gross proceeds of up to $1,250,000.
DIAGNOS Announces Three Year Contract with First U.S. Based Primary Care Network, Chaparral Medical Group in California
Marketwire - Wed Feb 12, 9:01AM CST
Diagnos Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis, and image processing, announced today the signing of a Contract with California-based Chaparral Medical Group for the deployment and usage of CARA, for diabetic retinopathy screening platform in that state.
DIAGNOS Announces Changes to its Board of Directors
Marketwire - Thu Jul 24, 3:01PM CDT
DIAGNOS Inc. ("DIAGNOS" or the "Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis and image processing, is pleased to announce the appointment of Mr. Lloyd M. Segal and Mr. Michael Singer as Directors of the Corporation following the resignations of Mr. Rich Baxter and Mr. Bruno Maruzzo. DIAGNOS Announces Yet Another Expansion of Successful Program in the UAE
Marketwire - Tue Jul 22, 8:31AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today a further expansion of the agreement first announced on November 26th 2013, with the first expansion announced on March 11, 2014, to further increase screening capacity in the country. DIAGNOS Announces Signing of Contract with Ministry of Health Owned Medical Center in the United Arab Emirates
Marketwire - Wed Jul 16, 8:30AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today the signing of a contract with Al Manama Medical Center for the deployment of a screening unit and usage of CARA in the Unite Arab Emirates, a project fully supported by the UAE Ministry of Health. Persistence Capital Partners Files Early Warning Report
CNW Group - Thu Jul 10, 9:00PM CDT
Persistence Capital Partners LP ("PCP"
, a leading Canadian private equity firm focused exclusively on investments in high growth opportunities in the healthcare field, is pleased to announce that, in connection with the completion of the three-cornered amalgamation (the "Amalgamation" among Warnex Inc. ("Warnex" and 8910979 Canada Inc., a wholly owned subsidiary of Diagnos Inc. ("Diagnos" which closed on July 8, 2014, PCP became a 13.76% shareholder of Diagnos. DIAGNOS Completes Merger with Warnex Inc. and Announces the Issuance of Stock Warrants
Marketwire - Tue Jul 08, 2:35PM CDT
DIAGNOS Inc. ("DIAGNOS"
(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce the closing of the merger (the "Merger" of Warnex Inc. ("WARNEX" with a wholly-owned subsidiary of DIAGNOS initially announced on May 5, 2014. Shareholders of Warnex Approve the Amalgamation With Diagnos
Marketwire - Fri Jun 27, 10:42AM CDT
DIAGNOS Inc. ("DIAGNOS"
(TSX VENTURE: ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis, and image processing, is pleased to announce that, at an annual and special meeting of the shareholders (the "Meeting" of Warnex Inc. ("Warnex" held yesterday, June 26, 2014, the shareholders of Warnex approved the terms of the amalgamation (the "Amalgamation" with a wholly-owned subsidiary of DIAGNOS initially announced on May 5, 2014. The Amalgamation was approved by 99.95% of Warnex shareholders voting in person or by proxy at the Meeting. Warnex and Diagnos enter into a pre-amalgamation agreement
CNW Group - Mon Jun 02, 7:08AM CDT
Pursuant to a binding letter of agreement entered into with Diagnos on May 5, 2014, Warnex Inc. (TSXV: WNX.H) ("Warnex"
is pleased to announce that it has entered into a pre-amalgamation agreement on May 30, 2014 (the "Pre-Amalgamation Agreement" with Diagnos Inc. ("Diagnos" , pursuant to which Warnex agreed to carry out an amalgamation (the "Amalgamation" under which Warnex will amalgamate with a wholly-owned subsidiary of Diagnos. DIAGNOS Announces Closing of First Tranche of Private Placement
Marketwire - Tue Apr 01, 9:01AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces the closing of first tranche, consisting of 77 units (the "Unit" , for gross proceeds of $770,000, of a non-brokered private placement consisting of up to 125 units, for gross proceeds of up to $1,250,000 previously announced on February 25, 2014. DIAGNOS Announces an Additional Expansion of Successful Program in the UAE
Marketwire - Tue Mar 11, 11:10AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis, and image processing, announced today a further expansion of the agreement announced on November 26th 2013 to further increase screening capacity in the country. Understanding Credit and Banking Sector
by Sanderson Abel - All Africa Global Media - Wed Feb 26, 4:43AM CST
It is important to realise that efficient allocation of savings through the identification and funding of entrepreneurs with the best chances of successfully implementing innovative products and production processes are tools to achieve the growth objective as enunciated in the Zimbabwe Agenda for Sustainable Socio-Economic Transformation (Zim-Asset) programme.
DIAGNOS Announces Private Placement
Marketwire - Tue Feb 25, 8:58AM CST
DIAGNOS inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces the intention of undertaking a non-brokered private placement consisting of up to 125 units (the "Unit" , for gross proceeds of up to $1,250,000. DIAGNOS Announces Three Year Contract with First U.S. Based Primary Care Network, Chaparral Medical Group in California
Marketwire - Wed Feb 12, 9:01AM CST
Diagnos Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis, and image processing, announced today the signing of a Contract with California-based Chaparral Medical Group for the deployment and usage of CARA, for diabetic retinopathy screening platform in that state. 
